I met up with endocrinologist and diabetes tech-expert Dr. David Ahn at ATTD to break down the biggest innovations from the conference. We get into the rise of fully closed-loop algorithms and what we should consider an "artificial pancreas". We also cover Abbott's dual glucose-ketone sensor, 21-day CGMs, GLP-1s in type 1 diabetes, AI-powered food analysis tools, and more.

Early access is for our All Access members only. You can sign up here.